AVITA Medical (ASX:AVH) appoints James Corbett as CEO

The Market Herald

2022-09-29

Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediately
Mr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience
He has been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks
Mr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017
AVITA is up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST

Regenerative medicine company AVITA Medical (AVH) has appointed James Corbett as CEO, effective immediately.

Mr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience.

He has previously been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks.

“Jim is an experienced strategist with significant commercial expertise that positions him well to lead AVITA Medical through its next stage of growth and beyond,” Chairman Lou Panaccio said.

“Having run a thorough process utilising a leading executive search firm, I am confident that Jim is the right leader for the company at this time.”

Mr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017.

“We are grateful to Dr Perry for his many contributions to AVITA Medical. We thank him for his commitment to AVITA Medical, its customers, employees, shareholders, and thepatients we serve,” Dr Panaccio concluded.

AVITA was up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2271763232"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2271763232\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2271763232?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-09-29 11:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2271763232","market":"us","top_or_hot":-1,"title":"AVITA Medical (ASX:AVH) appoints James Corbett as CEO","media":"The Market Herald","content":"<html><body><div>\n<ul><li>Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediately</li><li>Mr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience </li><li>He has been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks</li><li>Mr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017</li><li>AVITA is up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST</li></ul>\n<p>Regenerative medicine company AVITA Medical (AVH) has appointed James Corbett as CEO, effective immediately. </p>\n<p>Mr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience. </p>\n<p>He has previously been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks. </p>\n<p>“Jim is an experienced strategist with significant commercial expertise that positions him well to lead AVITA Medical through its next stage of growth and beyond,” Chairman Lou Panaccio said. </p>\n<p>“Having run a thorough process utilising a leading executive search firm, I am confident that Jim is the right leader for the company at this time.” </p>\n<p>Mr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017. </p>\n<p>“We are grateful to Dr Perry for his many contributions to AVITA Medical. We thank him for his commitment to AVITA Medical, its customers, employees, shareholders, and thepatients we serve,” Dr Panaccio concluded. </p>\n<p>AVITA was up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST.</p>\n</div></body></html>","source":"markerherald_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AVITA Medical (ASX:AVH) appoints James Corbett as CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAVITA Medical (ASX:AVH) appoints James Corbett as CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-29 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketherald.com.au/avita-medical-asxavh-appoints-james-corbett-as-ceo-2022-09-29/><strong>The Market Herald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediatelyMr Corbett has almost 40 years of experience in the life sciences field and has extensive global, ...</p>\n\n<a href=\"https://themarketherald.com.au/avita-medical-asxavh-appoints-james-corbett-as-ceo-2022-09-29/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XKO.AU","symbol_name":"标普/澳交所 300指数","start_time":0,"source_url":"https://themarketherald.com.au/avita-medical-asxavh-appoints-james-corbett-as-ceo-2022-09-29/","article_id":"2271763232","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2271763232","pubTimestamp":1664422140,"columns":[],"sourceInfo":{"source_id":"markerherald_stock","name":"The Market Herald"},"weMediaInfo":null,"summary":"Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediate","collect":0,"end_time":0,"defaultTopTitle":"themarketherald.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"XKO.AU":"标普/澳交所 300指数","BK7039":"金融交易所和数据","XAO.AU":"标普/澳交所 普通股指数","ASX.AU":"ASX LTD","ASX":"日月光半导体","XJO.AU":"标普/澳交所 200指数","AVH.AU":"Avita Therapeutics","BK7508":"医药生物股","BK4526":"热门中概股","BK7067":"生物科技","BK4141":"半导体产品"},"translate_title":"AVITA医疗公司（ASX：AVH）任命詹姆斯·科比特为首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ASX":1,"ASX.AU":1,"AVH":1,"AVH.AU":1,"XAO.AU":1,"XJO.AU":1,"XKO.AU":1},"content_text":"Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediatelyMr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience He has been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorksMr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017AVITA is up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST\nRegenerative medicine company AVITA Medical (AVH) has appointed James Corbett as CEO, effective immediately. \nMr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience. \nHe has previously been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks. \n“Jim is an experienced strategist with significant commercial expertise that positions him well to lead AVITA Medical through its next stage of growth and beyond,” Chairman Lou Panaccio said. \n“Having run a thorough process utilising a leading executive search firm, I am confident that Jim is the right leader for the company at this time.” \nMr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017. \n“We are grateful to Dr Perry for his many contributions to AVITA Medical. We thank him for his commitment to AVITA Medical, its customers, employees, shareholders, and thepatients we serve,” Dr Panaccio concluded. \nAVITA was up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}